Answer
Erenumab is a human monoclonal antibody that binds the CGRP receptor, potently and specifically competes with CGRP binding and inhibits its receptor function, with no significant activity against other calcitonin-family receptors.
Sources for this answer
- Aimovig solution for injection in pre filled penNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked